- Email: [email protected]
Obituary Federico Spreafico (1940–1994)
Int. J. lmmunopharmac., Vol. 16, No. 7, p. 495, 1994 Elsevier Science Ltd International Society for Immunopharmacology Printed in Great Britain 0192-0561/94 $7.00 + .00
~ ) Pergamon OBITUARY
FEDERICO SPREAFICO (1940-1994)
"'There was the Door to which I f o u n d no Key; There was the Veil through which I might not see'" Omar Khayyam
Today we mourn the loss of a Past President, but even more of a dear friend and a most gentle person. In our frequent conversations on the banks of the Seine, he used to emphasize that Science's principal merit was to drive men together, quoting Claude Bernard "Art is I, Science is We". Federico Spreafico obtained an M.D. degree at the University of Milan, and subsequently spent a two year period of postgraduate research at the National Institutes of Health (Bethesda, U.S.A.), before joining the Mario Negri Pharmacological Research Institute of Milan in 1969 as Head of the Laboratory of Immunology, and then Head of the Division of Oncology and Immunology. The main areas of research activity of the Division were, on the one hand, basic cellular immunology, immunopharmacology and immunotoxicology, and on the other hand, cancer chemotherapy. During his distinguished scientific career, he made a significant contribution to the Italian Biomedical Science (serving during two successive five year terms as Secretary General for the Progetti Finalizzati in Oncology of the Italian National Research Council) and to International Research Agencies in the governing bodies of the EORTC. He was an active member of many scientific societies, including
founding membership of the International Society of Immunopharmacology (1980) in which he served as Secretary, then as President Elect. In the fall of 1987, he joined the pharmaceutical company Farmitalia Carlo Erba in Milan as Head of the R&D program in Oncology, and became in 1991 Head of Development within R&D. Following the merger of FICE with the Swedish pharmaceutical company Kabi-Pharmacia, Federico Spreafico became a permanent member of the Corporate R&D Management Group of the new Pharmacia Corporation. During that period and not withstanding his career changes he had been unanimously elected President of our Society from 1988 to 1991. The Society was founded with the aim of being different in as much as it would be at the crossroads of several sciences and of several cultures. Federico Spreafico was very representative of this trend, being an M.D. who had worked in the most prestigious Research Institute of Italy and had become President of our Society while working in a large pharmaceutical industry. To his mother, his relations, his associates and his friends, we address our most sincere condolences. Louis CHEDID
495
~ ) Pergamon OBITUARY
FEDERICO SPREAFICO (1940-1994)
"'There was the Door to which I f o u n d no Key; There was the Veil through which I might not see'" Omar Khayyam
Today we mourn the loss of a Past President, but even more of a dear friend and a most gentle person. In our frequent conversations on the banks of the Seine, he used to emphasize that Science's principal merit was to drive men together, quoting Claude Bernard "Art is I, Science is We". Federico Spreafico obtained an M.D. degree at the University of Milan, and subsequently spent a two year period of postgraduate research at the National Institutes of Health (Bethesda, U.S.A.), before joining the Mario Negri Pharmacological Research Institute of Milan in 1969 as Head of the Laboratory of Immunology, and then Head of the Division of Oncology and Immunology. The main areas of research activity of the Division were, on the one hand, basic cellular immunology, immunopharmacology and immunotoxicology, and on the other hand, cancer chemotherapy. During his distinguished scientific career, he made a significant contribution to the Italian Biomedical Science (serving during two successive five year terms as Secretary General for the Progetti Finalizzati in Oncology of the Italian National Research Council) and to International Research Agencies in the governing bodies of the EORTC. He was an active member of many scientific societies, including
founding membership of the International Society of Immunopharmacology (1980) in which he served as Secretary, then as President Elect. In the fall of 1987, he joined the pharmaceutical company Farmitalia Carlo Erba in Milan as Head of the R&D program in Oncology, and became in 1991 Head of Development within R&D. Following the merger of FICE with the Swedish pharmaceutical company Kabi-Pharmacia, Federico Spreafico became a permanent member of the Corporate R&D Management Group of the new Pharmacia Corporation. During that period and not withstanding his career changes he had been unanimously elected President of our Society from 1988 to 1991. The Society was founded with the aim of being different in as much as it would be at the crossroads of several sciences and of several cultures. Federico Spreafico was very representative of this trend, being an M.D. who had worked in the most prestigious Research Institute of Italy and had become President of our Society while working in a large pharmaceutical industry. To his mother, his relations, his associates and his friends, we address our most sincere condolences. Louis CHEDID
495